Clause 9 - High Standards, Format, Suitability and Causing Offence, Sponsorship

9.1 High standards must be maintained at all times.

  • Clauses 9.1 and 9.2 Suitability and Taste

    The special nature of medicines and the professional audience to which the material is directed require that the standards set for the promotion of medicines are higher than those which might be acceptable for general commodity advertising.

    It follows therefore that certain types, styles and methods of promotion, even where they might be acceptable for the promotion of products other than medicines, are unacceptable. These include:

    • the display of naked or partially naked people for the purpose of attracting attention to the material or the use of sexual imagery for that purpose
    • ‘teaser’ advertising whereby promotional material is intended to ‘tease’ the recipient by eliciting an interest in something which will be following or will be available at a later date without providing any actual information about it
    • the use of inappropriate language abbreviations or emoticons particularly in digital communications
    • the provision of private prescription forms preprinted with the name of a medicine.

     

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

AUTH/3123/11/18 - Otsuka employee v Otsuka Europe Breach: 2, 9.1 Applicable Code: 2016 Received: 23 November 2018 Completed: 10 March 2022 AUTH/3041/6/18 and AUTH/3042/6/18 - Employee v Otsuka Europe and Otsuka UK Breach: 2, 4.1, 9.1 No breach: 4.1, 9.1 Applicable Code: 2016 Received: 01 June 2018 Completed: 10 March 2022 AUTH/3498/3/21 - Ex-employee v Leo Breach: 9.1, 27.7 No breach: 2, 9.1, 27.7 Applicable Code: 2019 Received: 29 March 2021 Completed: 18 November 2021 AUTH/3188/4/19 - Anonymous v Bayer Breach: 9.1 No breach: 2, 12.1, 19.2 Applicable Code: 2016 Received: 30 April 2019 Completed: 14 October 2020 AUTH/3190/4/20 - Anonymous v Takeda No breach: 2, 9.1, 12.1, 19.2 Applicable Code: 2016 Received: 30 April 2019 Completed: 14 October 2020 AUTH/3191/4/19 - Anonymous v Amgen No breach: 2, 9.1, 12.1, 19.2 Applicable Code: 2016 Received: 30 April 2019 Completed: 14 October 2020 AUTH/3193/4/19 - Anonymous v Novartis No breach: 2, 9.1, 12.1, 19.2 Applicable Code: 2016 Received: 30 April 2019 Completed: 14 October 2020 AUTH/3194/4/19 - Anonymous v GlaxoSmithKline No breach: 2, 9.1, 12.1, 19.2 Applicable Code: 2016 Received: 30 April 2019 Completed: 14 October 2020 AUTH/3195/4/19 - Anonymous v Chiesi No breach: 2, 9.1, 12.1, 19.2 Applicable Code: 2016 Received: 30 April 2019 Completed: 14 October 2020 AUTH/3197/4/19 - Anonymous v Ethypharm No breach: 2, 9.1, 12.1, 19.2 Applicable Code: 2016 Received: 30 April 2019 Completed: 14 October 2020 AUTH/3097/9/18 - Director v Teva No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 22 January 2020 AUTH/3084/9/18 - Director v Boehringer Ingelheim No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 22 January 2020 AUTH/3159/2/19 - Pharmacosmos v Vifor Breach: 12.1, 14.1 No breach: 2, 7.2, 9.1, 12.1 Applicable Code: 2016 Received: 13 February 2019 Completed: 13 December 2019 AUTH/3185/4/19 - Complainant v Mundibiopharma Breach: 4.1, 7.2, 7.3, 9.1, 14.1 No breach: 2, 4.1, 7.8 Applicable Code: 2016 Received: 26 April 2019 Completed: 27 November 2019 AUTH/3137/12/18 - ViiV Healthcare v Gilead Sciences Breach: 7.2, 7.3, 7.4, 7.10, 9.1, 8.1 No breach: 2, 7.2, 7.9 Applicable Code: 2016 Received: 20 December 2018 Completed: 18 November 2019 AUTH/3141/12/18 - Health Professional v Merck Sharp & Dohme Breach: 7.2, 24.1 No breach: 2, 9.1 Applicable Code: 2016 Received: 21 December 2018 Completed: 15 November 2019 AUTH/3178/3/19 - Anonymous v GlaxoSmithKline Breach: 4.1, 4.4, 9.1 No breach: 2, 4.1, 4.4, 7.2, 7.4, 3.2 Applicable Code: 2016 Received: 28 March 2019 Completed: 01 November 2019 AUTH/3180/4/19 - Respiratory nurse v AstraZeneca Breach: 9.1, 15.2 No breach: 9.1, 15.2 Applicable Code: 2016 Received: 04 April 2019 Completed: 29 October 2019 AUTH/3175/3/19 - Anonymous v GlaxoSmithKline Breach: 3.2, 7.2, 9.1 No breach: 2 Applicable Code: 2016 Received: 22 March 2019 Completed: 18 October 2019 AUTH/3174/3/19 - Anonymous Employees v Otsuka Europe Breach: 2, 9.1, 12.1 Applicable Code: 2016 Received: 20 March 2019 Completed: 16 October 2019 AUTH/3151/1/19 - Anonymous Employees v Otsuka Europe Breach: 2, 9.1 No breach: 4.1 Applicable Code: 2016 Received: 24 January 2019 Completed: 16 October 2019 AUTH/3173/3/19 - Anonymous v Novo Nordisk Breach: 15.2 No breach: 1.11, 2, 9.1, 9.10, 12.1, 26.1 Applicable Code: 2016 Received: 18 March 2019 Completed: 14 October 2019 AUTH/3182/4/19 - Pharmacist v Astellas Breach: 15.2, 15.4 No breach: 9.1, 15.9 Applicable Code: 2016 Received: 10 April 2019 Completed: 02 October 2019 AUTH/3177/3/19 - Anonymous v Grunenthal Breach: 4.1, 4.3, 4.9, 9.1, 9.9, 14.1, 26.1, 26.2, 28.1 No breach: 7.10, 16.1, 26.3 Applicable Code: 2016 Received: 19 March 2019 Completed: 02 October 2019 AUTH/3176/3/19 - Complainant v Orion Breach: 9.1, 9.10 No breach: 2, 4.1, 4.3, 4.4, 4.6, 4.8, 4.9, 12.1, 14.1 Applicable Code: 2016 Received: 23 March 2019 Completed: 02 October 2019 AUTH/2979/9/17 - Anonymous, non-contactable complainant v PharmaMar Certification and Promotion of Yondelis Breach: 2, 3.2, 7.2, 7.4, 9.1, 12.1, 14.1 Applicable Code: 2016 Received: 21 September 2017 Completed: 18 September 2019 AUTH/3102/9/18: Director v Lilly – Clinical trial disclosure No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 18 September 2019 AUTH/3079/9/18 - Director v Pfizer No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 18 September 2019 AUTH/3118/11/18 - Director v Tesaro No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 21 November 2018 Completed: 18 September 2019 AUTH/3087/9/18 - Director v GlaxoSmithKline No breach: 1.11, 2, 9.1 Applicable Code: Received: 12 September 2019 Completed: 18 September 2019 AUTH/3165/2/19 - Gilead Sciences v ViiV Healthcare No breach: 2, 3.2, 7.2, 7.3, 7.4, 9.1 Applicable Code: 2016 Received: 22 February 2019 Completed: 16 September 2019 AUTH/3046/6/18 - Anonymous v AstraZeneca Failure to publish joint working executive summary No breach: 9.1, 20 Applicable Code: 2016 Received: 01 June 2018 Completed: 27 August 2019 AUTH/3138/12/18 - Ex-employee v Indivior Breach: 2, 9.1, 24.1, 24.4 No breach: 24.6 Applicable Code: 2016 Received: 20 December 2018 Completed: 19 August 2019 AUTH/3064/9/18 - Gilead Sciences v ViiV Healthcare Breach: 7.2, 7.3, 7.4, 7.9, 9.1 No breach: 7.2, 7.10 Applicable Code: 2016 Received: 07 September 2018 Completed: 15 August 2019 AUTH/3140/12/18 - Health professional v Amgen Breach: 7.2, 9.1, 24.1 No breach: 7.2, 9.1, 2, 24.1 Applicable Code: 2016 Received: 21 December 2018 Completed: 10 August 2019 AUTH/3130/12/18 - Anonymous v GlaxoSmithKline Breach: 9.1, 26.1, 26.2 No breach: 2, 9.1, 12.1, 22.1, 22.4 Applicable Code: 2016 Received: 07 December 2018 Completed: 09 August 2019 AUTH/3133/12/18 - Anonymous v Novo Nordisk Breach: 9.1, 9.10, 22.4 No breach: 2, 14, 18, 19, 20, 23, 24, 26, 28 Applicable Code: 2016 Received: 11 December 2018 Completed: 30 July 2019 AUTH/3091/9/18 - Director v UCB Breach: 9.1 No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 22 July 2019 AUTH/3099/9/18 - Director v Allergan Breach: 9.1 No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 18 July 2019 AUTH/3128/12/18 - Complainant v Janssen Breach: 7.2, 7.4, 9.1 No breach: 7.2 Applicable Code: 2016 Received: 02 December 2018 Completed: 12 July 2019 AUTH/2935/2/17 - Anonymous Ex-employee v Sunovion Promotion of Latuda Breach: 15.2, 15.9 No breach: 2, 9.1, 15.2, 15.9 Applicable Code: 2016 Received: 13 February 2017 Completed: 11 July 2019 AUTH/3169/3/19 - Voluntary admission from Otsuka Europe Breach: 2, 9.1, 29 No breach: 2, 29 Applicable Code: 2016 Received: 12 March 2019 Completed: 05 July 2019 AUTH/3153/1/19 - Anonymous v Otsuka Europe Breach: 2, 9.1, 14.1 No breach: 2, 9.1 Applicable Code: 2016 Received: 30 January 2019 Completed: 05 July 2019 AUTH/3109/10/18 - Complainant v AstraZeneca Breach: 7.2, 7.3, 9.1 No breach: 2, 3.2, 7.2, 7.3, 9.1 Applicable Code: 2016 Received: 29 October 2018 Completed: 05 July 2019 AUTH/3168/2/19 - Complainant v Janssen Breach: 4.1, 4.6, 7.2, 7.9, 9.1 No breach: 2, 4.2, 4.1, 4.3, 4.4, 7.2, 12.1, 14.1 Applicable Code: 2016 Received: 27 February 2019 Completed: 27 June 2019 AUTH/3167/2/19 - Complainant/Director v Novartis No breach: 2, 4.1, 9.1, 9.10, 12.1, 26.1, 29 Applicable Code: 2016 Received: 27 February 2019 Completed: 18 June 2019 AUTH/3166/2/19 - Complainant v Sanofi Breach: 9.1, 14.5, 26.1, 26.2 No breach: 2, 4.1, 4.2, 4.3, 4.4, 4.9, 9.9, 11.1, 12.1, 14.1, 16.1, 28.1, 28.6 Applicable Code: 2016 Received: 27 February 2019 Completed: 11 June 2019 AUTH/3031/4/18 - Anonymous health professional v Gilead Breach: 3.2, 7.2, 9.1 No breach: 2, 3.2, 7.2, 7.3, 7.4, 8.1, 9.1, 12.1 Applicable Code: 2016 Received: 19 April 2019 Completed: 03 June 2019 AUTH/3158/2/19 - Employee v Servier No breach: 2, 7.2, 7.4, 7.9, 9.1, 12.1, 15.9, 23.1, 25.1 Applicable Code: 2016 Received: 05 February 2019 Completed: 30 May 2019 AUTH/3164/2/19 - Anonymous v Merck Sharp & Dohme No breach: 4.1, 9.1, 12.1 Applicable Code: 2016 Received: 18 February 2019 Completed: 28 May 2019 AUTH/3112/11/18 - Complainant v Lilly Breach: 9.1 No breach: 4.6, 4.10, 12.1, 14.5 Applicable Code: 2016 Received: 04 November 2018 Completed: 25 May 2019 AUTH/3154/2/19 - Anonymous contactable health professional v Dr Falk Pharma Breach: 4.1, 9.1 No breach: 2, 4.1, 4.3, 12.1 Applicable Code: 2016 Received: 04 February 2019 Completed: 24 May 2019 AUTH/3053/7/18 - Anonymous doctor v Daiichi-Sankyo Breach: 9.1, 22.1 No breach: 2, 23.1 Applicable Code: 2016 Received: 17 July 2018 Completed: 22 May 2019 AUTH/2939/2/17 and AUTH/2940/2/17 - Voluntary admissions by Astellas UK and Astellas Europe Failure to provide accurate prescribing information Breach: 2, 4.1, 9.1 No breach: 4.10, 26.3 Applicable Code: 2016 Received: 21 February 2017 Completed: 22 May 2019 AUTH/2883/10/16 - Voluntary admission by Astellas UK Patient support programmes Breach: 2, 7.2, 7.9, 7.11, 9.1, 14.3, 14.5, 21, 24.1 No breach: 2, 9.1, 14.1, 26.1 Applicable Code: 2016 Received: 18 October 2016 Completed: 22 May 2019 AUTH/3043/6/18 - Anonymous v Novartis Failure to publish joint working executive summary No breach: 2, 9.1, 20 Applicable Code: 2016 Received: 01 June 2018 Completed: 22 May 2019 AUTH/3070/9/18 - Director v Janssen No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3096/9/18 - Director v Shire No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3098/9/18 - Director v A Menarini No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3090/9/18 - Director v Novartis No breach: 1.11, 2, 9.1, 29 Applicable Code: 2016 Received: 12 September 2019 Completed: 15 May 2019 AUTH/3086/9/18 - Director v Merck Sharp & Dohme No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3093/9/18 - Director v Roche No breach: 1.11, 2, 9.1, 29 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3088/9/18 - Director v Ipsen No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2019 Completed: 15 May 2019 AUTH/3081/9/18 - Director v Astellas UK No breach: 1.11, 2, 9.1 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3085/9/18 - Director v Biogen No breach: 1.11, 2, 9.1, 29 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3080/9/18 - Director v Takeda No breach: 1.11, 9.1, 2, 29 Applicable Code: Received: 12 September 2018 Completed: 15 May 2019 AUTH/3078/9/18 - Director v Amgen No breach: 1.11, 2, 9.1, 29 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3069/9/18 - Director v Bayer No breach: 1.11, 2, 9.1, 29 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3071/9/18 - Director v Novo Nordisk No breach: 1.11, 2, 9.1, 29 Applicable Code: 2016 Received: 12 September 2018 Completed: 15 May 2019 AUTH/3162/2/19 - Complainant v AstraZeneca No breach: 9.1, 14.3, 14.5, 16.1, 28.6 Applicable Code: 2016 Received: 19 February 2019 Completed: 09 May 2019 AUTH/3157/2/19 - Voluntary admission by AstraZeneca Breach: 7.2, 7.4, 9.1 Applicable Code: 2016 Received: 12 February 2019 Completed: 08 May 2019 AUTH/3067/9/18 - Member of the public v Chiesi Breach: 9.1 No breach: 2, 9.1, 14.1 Applicable Code: 2016 Received: 25 September 2018 Completed: 03 May 2019 AUTH/3155/2/19 and AUTH/3156/2/19 - Complainant v Bristol-Myers Squibb and Pfizer Breach: 7.2, 9.1 No breach: 2, 3.2 Applicable Code: 2016 Received: 05 February 2019 Completed: 02 May 2019 AUTH/3142/1/19 - Complainant v Sanofi Online advertisement  No breach: 9.1, 11.1, 26.1, 26.2 Applicable Code: 2019 Received: 07 January 2019 Completed: 24 April 2019 AUTH/3066/9/18 - Head of medicines optimisation v GlaxoSmithKline Breach: 7.1, 7.2, 7.4, 7.5, 9.1 Applicable Code: 2016 Received: 21 September 2018 Completed: 17 April 2019 AUTH/3134/12/18 Complainant v Shield Breach: 3.2, 7.2, 9.1 No breach: 2 Applicable Code: 2016 Received: 17 December 2018 Completed: 02 April 2019 AUTH/3121/11/18 - Health Professional v Biogen Idec No breach: 9.1 Applicable Code: 2016 Received: 07 November 2018 Completed: 28 March 2019 AUTH/3126/11/18 - Complainant v Alliance Pharmaceuticals Breach: 9.1, 26.1, 26.2 No breach: 2 Applicable Code: 2016 Received: 29 November 2018 Completed: 20 March 2019 AUTH/3143/1/19 - Tillotts v Ferring Breach: 9.1 Applicable Code: 2019 Received: 07 January 2019 Completed: 19 March 2019 AUTH/3056/8/18 - Ex-representative vs GlaxoSmithKline – Conduct of GlaxoSmithKline Breach: 3.2, 7.2, 9.1 No breach: 2, 3.2, 7.2, 9.1, 15.9, 18.1, 19.1, 19.2, 23.1 Applicable Code: 2016 Received: 31 July 2018 Completed: 12 March 2019 AUTH/3105/10/18- Pharmacy team leader v Eli Lilly No breach: 2, 9.1, 15.4 Applicable Code: 2016 Received: 08 October 2018 Completed: 25 February 2019 AUTH/3107/10/18 - Complainant v Daiichi-Sankyo Breach: 9.1, 26.1, 28.1 No breach: 2 Applicable Code: 2016 Received: 29 October 2018 Completed: 22 February 2019 AUTH/3127/12/18 - Voluntary admission by Merck Sharp & Dohme Breach: 4.1, 14.1 No breach: 9.1 Applicable Code: 2016 Received: 30 November 2018 Completed: 21 February 2019 AUTH/3108/10/18 - Complainant v Mitsubishi Tanabe Pharma Europe Breach: 9.1, 26.1, 28.1 No breach: 2 Applicable Code: 2016 Received: 29 October 2018 Completed: 20 February 2019 AUTH/3051/6/18 - Complainant v Alexion Breach: 9.1 No breach: 2, 9.9, 26.1, 26.2 Applicable Code: 2016 Received: 26 June 2018 Completed: 14 February 2019 AUTH/3045/6/18 - Anonymous v Pfizer Failure to publish joint working executive summary No breach: 9.1, 20 Applicable Code: 2016 Received: 01 June 2018 Completed: 17 January 2019 AUTH/3125/11/18 - Takeda v Merck Sharp & Dohme Inter-company dialogue Breach: 9.1 Applicable Code: 2016 Received: 23 November 2018 Completed: 09 January 2019 AUTH/3110/10/18 - Anonymous v Napp Colour of inverted triangle symbol Breach: 9.1 No breach: 4.1 Applicable Code: 2016 Received: 29 October 2018 Completed: 03 January 2019 AUTH/3029/4/18 - Complainant v GW Pharmaceuticals Arrangements for a meeting, alleged promotion of Epidiolex and unapproved slides No breach: 2, 3.1, 9.1, 14.1, 15.2, 22.1 Applicable Code: 2016 Received: 05 April 2018 Completed: 21 December 2018 AUTH/3026/3/18 - Anonymous Employee v Sanofi Promotion of Toujeo and Lantus Breach: 9.1, 15.9 No breach: 2, 9.1, 3.2, 15.2, 15.9 Applicable Code: 2016 Received: 16 March 2018 Completed: 19 December 2018 AUTH/3060/8/18 - Pharmacist v Proveca Letter regarding the supply of unlicensed and off-label glycopyrronium Breach: 2, 9.1 Applicable Code: 2016 Received: 21 August 2018 Completed: 11 December 2018 AUTH/3103/10/18 - Anonymous v Ipsen Promotion of Cabometyx Breach: 3.2 No breach: 2, 7.2, 7.4, 7.9, 9.1 Applicable Code: 2016 Received: 03 October 2018 Completed: 06 December 2018 AUTH/3038/4/18 - Health professional v Novartis Conduct of an employee on LinkedIn Breach: 9.1, 14.1, 26.2, 26.1 No breach: 2, 14.1, 14.3, 26.1, 26.2 Applicable Code: 2016 Received: 25 April 2018 Completed: 05 December 2018 AUTH/3014/1/18 - Anonymous, non-contactable health professional v GW Pharmaceuticals Promotion of Epidiolex Breach: 2, 3.1, 9.1 No breach: 2, 3.1, 9.1, 7.2, 15.2 Applicable Code: 2016 Received: 22 February 2018 Completed: 22 November 2018 AUTH/3104/10/18 - Anonymous Health Professional v Merck Serono Terms of trade No breach: 2, 9.1, 18.1, 19.1, 19.2 Applicable Code: 2016 Received: 09 October 2018 Completed: 21 November 2018 AUTH/3044/6/18 - Anonymous v Roche Failure to publish joint working executive summary Breach: 9.1, 20 No breach: 2 Applicable Code: 2016 Received: 01 June 2018 Completed: 12 November 2018 AUTH/3063/9/18 - Voluntary admission by Dr Falk Pharma Promotion to the public via YouTube Breach: 9.1, 14.1, 26.1, 26.2 No breach: 2, 26.1, 26.2 Applicable Code: 2016 Received: 06 September 2018 Completed: 12 November 2018 AUTH/3061/8/18 - Health professional v Ferring Conduct of a representative No breach: 9.1, 15.2, 15.4, 15.9 Applicable Code: 2016 Received: 21 August 2018 Completed: 26 October 2018 AUTH/3024/3/18 - Anonymous , non-contactable Hospital Consultant v GW Pharmaceuticals Alleged promotion of Epidiolex No breach: 2, 9.1, 3.1, 15.2 Applicable Code: 2016 Received: 12 March 2018 Completed: 18 October 2018 AUTH/3054/7/18 - Anonymous v PharmaMar Meeting in Madrid Breach: 9.1, 22.1 No breach: 2, 9.1, 22.1 Applicable Code: 2016 Received: 13 July 2018 Completed: 18 October 2018 AUTH/3010/1/18 - Bristol-Myers Squibb and Pfizer v Daiichi-Sankyo Promotion of Lixiana Breach: 2, 7.10 No breach: 2, 7.9, 9.1, 26.1, 26.2 Applicable Code: 2016 Received: 12 January 2018 Completed: 17 October 2018 AUTH/3028/3/18 - Ex-Employee v AbbVie Production of a poster and use of case studies Breach: 9.1, 9.10, 14.1 No breach: 2, 15.2 Applicable Code: 2016 Received: 23 March 2018 Completed: 17 October 2018 AUTH/3057/8/18 - Clinical Commissioning Group employee v Novo Nordisk Conduct of a representative No breach: 2, 3.2, 9.1, 15.2 Applicable Code: 2016 Received: 15 August 2018 Completed: 16 October 2018 AUTH/3035/4/18 - Health Professional v Bayer Promotion of Xarelto Breach: 2, 7.2, 7.4, 9.1 Applicable Code: 2016 Received: 26 April 2018 Completed: 08 October 2018 AUTH/3047/6/18 - Health professional v A Menarini Promotion of Migard Breach: 4.1, 4.4, 9.1 No breach: 2 Applicable Code: 2016 Received: 08 June 2018 Completed: 03 September 2018 AUTH/3033/4/18 - Boehringer Ingelheim and Lilly v Novo Nordisk Promotion of Victoza No breach: 3.2, 7.2, 7.8, 9.1 Applicable Code: 2016 Received: 24 April 2018 Completed: 28 August 2018 AUTH/3037/4/18 - Health professional v Shield Promotion of Feraccru and unlicensed medicines to the public Breach: 2, 3.1, 4.1, 4.6, 9.1, 14.3, 26.1, 28.1 No breach: 2, 26.1 Applicable Code: 2016 Received: 26 April 2018 Completed: 24 August 2018 AUTH/3049/6/18 - Anonymous v Bristol-Myers Squibb Colour of inverted triangle Breach: 9.1 No breach: 4.10 Applicable Code: 2016 Received: 11 June 2018 Completed: 15 August 2018 AUTH/3017/2/18 - Anonymous contactable v Celgene Certification and approval of material for meetings Breach: 9.1, 14.1, 15.9 No breach: 2, 9.1, 14.1 Applicable Code: 2016 Received: 31 January 2018 Completed: 02 August 2018 AUTH/2987/10/17- Anonymous v Shire Alleged promotion prior to the grant of a marketing authorisation Breach: 9.1, 12.2 No breach: 2, 3.1, 9.1, 18.1 Applicable Code: 2016 Received: 25 October 2017 Completed: 31 July 2018 AUTH/2997/12/17 - Anonymous health professional v AbbVie Promotion of Synagis Breach: 9.1, 14.1 No breach: 2, 7.2, 7.4, 9.1, 15.2 Applicable Code: 2016 Received: 18 December 2017 Completed: 17 July 2018 AUTH/3039/5/18 - Tillotts v Dr Falk Promotion of Budenofalk Breach: 7.2, 9.1 No breach: 7.2, 9.1 Applicable Code: 2016 Received: 11 May 2018 Completed: 13 July 2018 AUTH/3036/4/18 - Health professional v Concordia Promotion of Morphgesic SR No breach: 2, 4.1, 9.1 Applicable Code: 2016 Received: 24 April 2018 Completed: 12 July 2018 AUTH/3030/4/18 - Anonymous employee v UCB Activities under the Code No breach: 2, 9.1, 14.1, 15.3, 15.4, 15.9 Applicable Code: 2016 Received: 06 April 2018 Completed: 03 July 2018 AUTH/3018/2/18 - Voluntary admission from Tesaro Failure to certify material before use Breach: 9.1, 14.1 Applicable Code: 2016 Received: 09 February 2018 Completed: 31 May 2018 AUTH/2996/12/17 - Pharmacist v Seqirus Promotion of Fluad No breach: 7.2, 7.3, 7.4, 9.1, 10.2 Applicable Code: 2016 Received: 14 December 2017 Completed: 10 May 2018 AUTH/3011/1/18 - GlaxoSmithKline v AstraZeneca Press release issued by AstraZeneca Breach: 7.2, 7.3, 7.9, 7.10, 9.1, 26.2 No breach: 2, 7.4, 7.5, 26.1, 26.2, 26.3 Applicable Code: 2016 Received: 18 January 2018 Completed: 04 May 2018 AUTH/2831/4/16 - Voluntary admission by Celgene Meetings organised by representatives Breach: 2, 4.1, 4.10, 9.1, 14.1, 15.2, 18.1, 26.1 Applicable Code: 2016 Received: 01 April 2016 Completed: 18 April 2018 AUTH/2971/8/17 - Clinical Commissioning Group v Thame Laboratories Promotion of Thamicarb Breach: 2, 3.2, 7.2, 7.4, 8.2, 9.1, 9.5 Applicable Code: 2016 Received: 17 August 2017 Completed: 18 April 2018 AUTH/3013/1/18 - AstraZeneca employee v AstraZeneca Breach: 9.1, 14.2 No breach: 2, 18.1, 23.1 Applicable Code: 2016 Received: 23 January 2018 Completed: 10 April 2018 AUTH/3022/2/18 and AUTH/3023/2/18 - Health professionals v Servier Alleged sponsorship of a meeting No breach: 2, 9.1, 22.1, 22.2 Applicable Code: 2016 Received: 23 February 2018 Completed: 10 April 2018 AUTH/3008/1/18 - Teva v Pharmasure Provision of a chocolate hamper Breach: 2, 9.1, 18.1 No breach: 15.2 Applicable Code: 2016 Received: 22 December 2017 Completed: 22 March 2018 AUTH/2965/8/17 - Anonymous employee v Biogen Company culture and bonus scheme Breach: 2, 15.7 No breach: 2, 9.1, 15.7 Applicable Code: 2016 Received: 07 August 2017 Completed: 22 March 2018 AUTH/3012/1/18 - Voluntary admission by Pierre Fabre Failure to certify material Breach: 2, 3.1, 7.2, 7.4, 9.1, 14.1, 15.9 No breach: 4.8 Applicable Code: 2016 Received: 19 January 2018 Completed: 21 March 2018 AUTH/2982/10/17 - Member of the public v Leo Promotion of Kyntheum to the public No breach: 2, 3.1, 7.2, 7.4, 9.1, 26.1 Applicable Code: 2016 Received: 06 October 2017 Completed: 08 February 2018 AUTH/2993/11/17 - Complainant v Napp Activities of Napp No breach: 2, 9.1, 19.2 Applicable Code: 2016 Received: 29 November 2017 Completed: 07 February 2018 AUTH/2970/8/17 - Anonymous v Janssen Promotional email Breach: 9.1, 15.2 No breach: 2, 7.2, 7.4, 9.1, 12.1, 16.1 Applicable Code: 2016 Received: 10 August 2017 Completed: 01 February 2018 AUTH/2978/9/17 - Anonymous consultant dermatologist v Janssen Alleged Promotion of Tremfya Breach: 2, 3.1, 9.1 Applicable Code: 2016 Received: 21 September 2017 Completed: 29 January 2018 AUTH/2969/8/17 - Senior Practice Nurse v AstraZeneca Conduct of a representative Breach: 9.1, 15.2 No breach: 2, 7.2, 7.4, 8.1, 15.2, 15.4, 15.9 Applicable Code: 2016 Received: 03 August 2017 Completed: 26 January 2018 AUTH/2988/10/17 - Employee v Otsuka Manager’s use of LinkedIn to promote medicines Breach: 3.1, 3.2, 4.1, 7.2, 9.1, 14.1, 26.1 No breach: 1.2, 2, 9.10, 12.1, 22, 26.1 Applicable Code: 2016 Received: 31 October 2017 Completed: 25 January 2018 AUTH/2983/10/17 - Anonymous, non-contactable v Celgene Promotion of Abraxane to the public Breach: 9.1, 26.2 No breach: 2, 26.1, 26.2 Applicable Code: 2016 Received: 09 October 2017 Completed: 18 January 2018 AUTH/2991/11/17 and AUTH/2992/11/17 - Anonymous v Pfizer and Bristol Myers Squibb Meeting arrangements No breach: 2, 9.1, 22.1 Applicable Code: 2016 Received: 14 November 2017 Completed: 17 January 2018 AUTH/2986/10/17 - Anonymous, non-contactable v Teva Conduct of a representative Breach: 15.2 No breach: 2, 9.1, 15.3, 15.5 Applicable Code: 2016 Received: 25 October 2017 Completed: 11 January 2018 AUTH/2962/7/17 - Sales representative v Pierre Fabre Call rates and certification of meetings Breach: 2, 9.1, 14.1, 15.9 No breach: 9.1, 14.1, 15.4, 15.9, 16.3 Applicable Code: 2016 Received: 31 July 2017 Completed: 05 January 2018 AUTH/2972/8/17 - Anonymous healthcare journalist v UCB UCB website Breach: 2, 7.2, 9.1, 14.5, 26.2 No breach: 14.3, 26.3 Applicable Code: 2016 Received: 18 August 2017 Completed: 19 December 2017 AUTH/2981/9/17 - Member of the public v ViiV Use of an iPad in public No breach: 2, 9.1, 15.2, 26.1 Applicable Code: 2016 Received: 26 September 2017 Completed: 23 November 2017 AUTH/2976/9/17 - Hospital Consultant v AstraZeneca Email promotion of Qtern Breach: 7.2, 9.1, 9.9, 11.1, 12.1 Applicable Code: 2016 Received: 09 September 2017 Completed: 20 November 2017 AUTH/2974/9/17 - Anonymous Clinician v ViiV Healthcare Alleged promotion to the public No breach: 2, 4.1, 9.1, 26.1 Applicable Code: 2016 Received: 07 September 2017 Completed: 14 November 2017 AUTH/2825/3/16 and AUTH/2826/3/16 - Janssen-Cilag v Boehringer Ingelheim and Lilly Promotion of Jardiance Breach: 2, 3.2, 9.1, 12.1 No breach: 1.12 Applicable Code: 2016 Received: 03 March 2016 Completed: 12 October 2017 AUTH/2951/4/17 - Consultant physician v Sanofi Promotion of Toujeo Breach: 7.2, 7.4, 9.1, 15.9 No breach: 7.2 Applicable Code: 2016 Received: 06 April 2017 Completed: 12 September 2017 AUTH/2956/5/17 - Ex-employee v Napp Flutiform promotional practices No breach: 2, 7.2, 7.4, 9.1, 15.9, 19.1, 19.2 Applicable Code: 2016 Received: 08 May 2017 Completed: 29 August 2017 AUTH/2953/4/17 - Tillotts v Dr Falk Promotion of Salofalk Granules Breach: 7.2, 7.3, 7.4, 7.10 No breach: 7.3, 7.4, 7.10, 8.1, 9.1 Applicable Code: 2016 Received: 18 April 2017 Completed: 17 August 2017 AUTH/2960/6/17 - Hospital Doctor v A Menarini Certification of company website Breach: 2, 9.1, 14.3, 14.5, 14.6 No breach: 14.1 Applicable Code: 2016 Received: 12 June 2017 Completed: 09 August 2017 AUTH/2923/12/16 - Hospital Pharmacist v Merck Sharp & Dohme Remicade advertisement Breach: 7.2, 7.10 No breach: 2, 3.2, 7.8, 9.1, 9.7 Applicable Code: 2016 Received: 21 December 2016 Completed: 07 August 2017 AUTH/2955/4/17 - Anonymous Employee v Boehringer Ingelheim Call rates No breach: 2, 9.1, 15.4, 15.9 Applicable Code: 2016 Received: 25 April 2017 Completed: 01 August 2017 AUTH/2948/3/17 - General Practitioner v Novo Nordisk Promotion of Tresiba Breach: 7.2, 7.3 No breach: 7.2, 7.3, 9.1, 9.9 Applicable Code: 2016 Received: 21 March 2017 Completed: 21 July 2017 AUTH/2943/3/17 - Ex-employee of a service provider v Bayer Conduct of an employee Breach: 2, 9.1, 15.9 No breach: 3.2, 8.2, 9.1, 15.2 Applicable Code: 2016 Received: 08 March 2017 Completed: 21 July 2017 AUTH/2957/5/17 - Voluntary admission by Astellas UK Omission of prescribing information Breach: 2, 4.1, 9.1 Applicable Code: 2016 Received: 23 May 2017 Completed: 19 July 2017 AUTH/2958/5/17 - Voluntary admission by Astellas Europe Use of withdrawn advertisement Breach: 2, 7.11, 9.1, 14.1 Applicable Code: 2016 Received: 23 May 2017 Completed: 17 July 2017 AUTH/2947/3/17 - Anonymous v Sanofi Representatives’ call rates Breach: 9.1, 15.9 No breach: 15.4, 15.1, 15.9 Applicable Code: 2016 Received: 22 March 2017 Completed: 14 July 2017 AUTH/2954/4/17 - Health professional v AstraZeneca Conduct of a representative Breach: 7.2, 7.4, 9.1, 15.2, 15.4, 15.9 Applicable Code: 2016 Received: 18 April 2017 Completed: 12 July 2017 AUTH/2928/1/17 and AUTH/2929/1/17 - Anonymous v Pfizer and Novartis Pharmacovigilance compliance, promotion of an unlicensed indication and breach of undertaking Breach: 2, 3.2, 9.1, 7.2, 15.9, 29 No breach: 2, 3.2, 7.2, 9.1, 15.6, 15.9, 16.2, 25.1, 29 Applicable Code: 2016 Received: 04 January 2017 Completed: 06 July 2017 AUTH/2946/3/17 - Anonymous Consultant Oncologist v Merck Serono Conduct of representative No breach: 7.1, 7.5, 9.1, 11.2, 15.2, 15.4, 15.9 Applicable Code: 2016 Received: 20 February 2017 Completed: 28 June 2017 AUTH/2931/1/17 - Health professional consultant to a pharmaceutical company/Director v Pfizer Online advertisement for a meeting Breach: 9.2 No breach: 2, 4.1, 4.9, 7.10, 9.1, 29 Applicable Code: 2016 Received: 16 January 2017 Completed: 27 June 2017 AUTH/2961/6/17 - Indivior v Martindale Promotion of Espranor and information to the public Breach: 2, 7.2, 7.3, 7.4, 7.9, 9.1, 26.1, 26.2 No breach: 7.2, 7.3, 7.4, 7.6, 9.1 Applicable Code: 2016 Received: 26 June 2017 Completed: 27 June 2017 AUTH/2950/4/17 - Health professional v Tor Generics Advertisement in The Big Issue Breach: 2, 9.1 No breach: 26.1 Applicable Code: 2016 Received: 01 April 2017 Completed: 09 June 2017 AUTH/2949/3/17 - Hospital doctor v A Menarini Yellow Card Scheme details missing from company website Breach: 9.1, 26.3 No breach: 4.9 Applicable Code: 2016 Received: 24 March 2017 Completed: 07 June 2017 AUTH/2942/2/17 - Health professional consultant to a pharmaceutical company v Boehringer ingelheim Online Spiolto advertisement No breach: 4.1, 4.3, 7.2, 7.4, 9.1 Applicable Code: 2016 Received: 01 March 2017 Completed: 15 May 2017 AUTH/2934/2/17 - Health professional consultant to a pharmaceutical company v Johnson & Johnson Promotion of Nicorette Breach: 4.4 No breach: 4.1, 4.3, 9.1, 11.1, 26.1 Applicable Code: 2016 Received: 08 February 2017 Completed: 10 May 2017 AUTH/2941/2/17 - Health professional consultant to a pharmaceutical company v Merck Sharp & Dohme Invitation to webcast No breach: 4.1, 9.1 Applicable Code: 2016 Received: 23 February 2017 Completed: 09 May 2017 AUTH/2884/10/16 - Clinical commissioning group member v Intrapharm Letters to GP practices Breach: 7.2, 7.4, 9.1 Applicable Code: 2016 Received: 19 October 2016 Completed: 05 May 2017 AUTH/2933/2/17 - Health professional consultant to a pharmaceutical company v Chiesi Promotion of Fostair Breach: 7.2 No breach: 2, 4.1, 9.1 Applicable Code: 2016 Received: 08 February 2017 Completed: 02 May 2017 AUTH/2936/2/17 - Health professional consultant to a pharmaceutical company v Johnson & Johnson Online Nicorette advertisement No breach: 7.2, 9.1 Applicable Code: 2016 Received: 15 February 2017 Completed: 27 April 2017 AUTH/2889/11/16 - Ex-employee v AstraZeneca Websites Breach: 4.1, 4.6, 7.2, 7.3 No breach: 2, 4.1, 7.2, 9.1, 14.5 Applicable Code: 2016 Received: 18 November 2016 Completed: 07 April 2017 AUTH/2890/11/16 - Health professional v Novo Nordisk Company website Breach: 9.10, 14.5, 26.2 No breach: 4.1, 4.6, 9.1, 14.5, 26.1 Applicable Code: 2016 Received: 18 November 2016 Completed: 04 April 2017 AUTH/2925/1/17 - A health professional v Pfizer Websites Breach: 4.1, 9.1 No breach: 4.1 Applicable Code: 2016 Received: 03 January 2017 Completed: 03 April 2017 AUTH/2912/12/16 - Voluntary admission by Astellas Pharma Europe Promotion of Betmiga to the public via social media and the Internet Breach: 9.1, 26.1, 26.2 No breach: 2, 26.1, 26.2 Applicable Code: 2016 Received: 05 December 2016 Completed: 03 April 2017 AUTH/2893/11/16 - Anonymous, non-contactable v GE Healthcare Promotion of Vizamyl Breach: 3.1, 7.2, 9.1 No breach: 2, 3.1, 3.2, 12, 16 Applicable Code: 2016 Received: 29 November 2016 Completed: 31 March 2017 AUTH/2920/12/16 - Anonymous, non-contactable ex-employee v UCB Promotion of Naloxone Minijet Breach: 9.1, 15.9 No breach: 2, 3.2 Applicable Code: 2016 Received: 20 December 2016 Completed: 27 March 2017 AUTH/2888/11/16 - Nurse v Napp Promoting a switch to Remsima Breach: 7.2, 7.4, 9.2, 9.1 No breach: 7.2, 7.4, 7.10 Applicable Code: 2016 Received: 17 November 2016 Completed: 01 March 2017 AUTH/2887/11/16 - Anonymous health professional v AstraZeneca Meeting attendees and speaker reference to Saxagliptin Breach: 9.1 No breach: 9.1, 11.1, 15.2, 22.1, 2 Applicable Code: 2016 Received: 14 November 2016 Completed: 10 February 2017 AUTH/2927/1/17 - Anonymous, non contactable v Roche Article on BBC website No breach: 2, 9.1, 26.2 Applicable Code: 2016 Received: 04 January 2017 Completed: 07 February 2017 AUTH/2918/12/16 - Ex-employee v GlaxoSmithKline Material on internal hosting server No breach: 4.1, 4.3, 4.9, 4.10, 9.1, 26.1 Applicable Code: 2016 Received: 19 December 2016 Completed: 03 February 2017 AUTH/2917/12/16 - Anonymous, non-contactable v Janssen Conduct of a representative Breach: 15.2 No breach: 2, 9.1 Applicable Code: 2016 Received: 21 December 2016 Completed: 31 January 2017 AUTH/2914/12/16 - Hospital pharmacist v Pierre Fabre Navelbine bags distributed by representatives Breach: 2, 9.1 Applicable Code: 2016 Received: 06 December 2016 Completed: 31 January 2017 AUTH/2924/12/16 - Pharmacist v Lincoln Medical Statements on website Breach: 9.1, 26.1, 28.1 No breach: 2 Applicable Code: 2016 Received: 21 December 2016 Completed: 30 January 2017 AUTH/2921/12/16 - Voluntary Admission by Grunenthal Promotion to the public Breach: 9.1, 26.1, 26.2 No breach: 2 Applicable Code: 2016 Received: 20 December 2016 Completed: 29 January 2017 AUTH/2919/12/16 - Anonymous, non-contactable v Merck Sharp & Dohme Conduct of representative No breach: 2, 9.1, 15.2 Applicable Code: 2016 Received: 14 December 2016 Completed: 20 January 2017 AUTH/2915/12/16 and AUTH/2916/12/16 - Anonymous v Janssen-Cilag and Napp Venue for promotional meeting No breach: 2, 9.1, 22.1 Applicable Code: 2016 Received: 12 December 2016 Completed: 20 January 2017 AUTH/2880/10/16 - Anonymous, Non Contactable v Bristol-Myers Squibb Alleged pre-licence of Opdivo No breach: 3.2, 9.1, 18.1, 22.1, 26.1, 26.2, 2 Applicable Code: 2016 Received: 11 October 2016 Completed: 19 January 2017 AUTH/2913/12/16 - Anonymous v Janssen Conduct of a medical science liaison employee No breach: 2, 3.1, 3.2, 9.1 Applicable Code: 2016 Received: 06 December 2016 Completed: 10 January 2017 AUTH/2868/8/16 - Janssen v Sanofi Genzyme Alleged promotion of an unlicensed medicine Breach: 3.1, 9.1 Applicable Code: 2016 Received: 10 August 2016 Completed: 19 December 2016 AUTH/2865/8/16 - Anonymous, non-contactable v Sanofi Engagement of consultant and his/her training and consultancy company No breach: 2, 9.1, 18.1, 19.1, 19.2, 21, 23.1 Applicable Code: 2016 Received: 03 August 2016 Completed: 19 December 2016 AUTH/2863/8/16 - Anonymous, non-contactable v Lilly Engagement of consultant and his/her training and consultancy company No breach: 2, 9.1, 18.1, 19.1, 19.2, 21, 23.1 Applicable Code: 2016 Received: 03 August 2016 Completed: 19 December 2016 AUTH/2828/3/16 - Clinical Nurse Specialist v Vifor Conduct of representatives Breach: 2, 7.2, 7.4, 7.9, 9.1, 9.9, 15.2, 15.9 No breach: 15.4 Applicable Code: 2016 Received: 21 March 2016 Completed: 07 December 2016 AUTH/2878/10/16 - Member of the public v Meda Alleged promotion to the public No breach: 2, 9.1, 26.1 Applicable Code: 2016 Received: 28 October 2016 Completed: 16 November 2016 AUTH/2874/9/16 - Health professional v Shield Promotion of Feraccru No breach: 2, 7.2, 9.1 Applicable Code: 2016 Received: 21 September 2016 Completed: 10 November 2016 AUTH/2872/9/16 - Consultant oncologist and a pharmacist v Lilly Oncology handbook No breach: 2, 7.2, 9.1 Applicable Code: 2016 Received: 12 September 2016 Completed: 09 November 2016 AUTH/2849/6/16 - Consultant oncologist and pharmacist v Lilly Oncology handbook Breach: 2, 7.2, 7.4, 9.1 No breach: 2, 9.1, 9.10, 12.1 Applicable Code: 2016 Received: 03 June 2016 Completed: 07 November 2016 AUTH/2873/9/16 - Anonymous, non-contactable v Actelion Hospitality at an exhibition stand Breach: 9.1, 22.1 Applicable Code: 2016 Received: 15 September 2016 Completed: 02 November 2016 AUTH/2867/8/16 - Anonymous, non contactable ex-employee v UCB Conduct of representatives Breach: 9.1, 15.4, 15.9 No breach: 2 Applicable Code: 2016 Received: 09 August 2016 Completed: 11 October 2016 AUTH/2871/8/16 - Voluntary admission by Janssen Pre-licence promotion Breach: 2, 3.2, 9.1, 14.1 Applicable Code: 2016 Received: 22 August 2016 Completed: 06 October 2016 AUTH/2857/7/16 - Anonymous, non-contactable v Daiichi-Sankyo Promotional activities and call rates Breach: 15.4, 15.9 No breach: 2, 3.1, 3.2, 4.1, 9.1, 14.1 Applicable Code: 2016 Received: 25 July 2016 Completed: 30 September 2016 AUTH/2840/4/16 and AUTH/2847/5/16 - Anonymous, non contactable v Novartis and Pfizer Promotion of Ultibro Breezhaler and Seebri Breezhaler Breach: 3.2, 7.2, 9.1, 15.9 No breach: 2, 3.2, 7.2, 9.1, 15.9 Applicable Code: 2016 Received: 25 April 2016 Completed: 16 September 2016 AUTH/2852/6/16 - Ex-employee v Grunenthal Medical science liaisons’ working practices No breach: 2, 3.2, 9.1, 11.1, 12.1, 15.2, 15.4, 15.9 Applicable Code: 2016 Received: 20 June 2016 Completed: 14 September 2016 AUTH/2860/7/16 - Health Professional v Chiesi Alleged promotion to the public No breach: 2, 9.1, 26.1 Applicable Code: 2016 Received: 25 July 2016 Completed: 08 September 2016 AUTH/2859/7/16 - Health Professional v AstraZeneca Alleged promotion to the public No breach: 2, 9.1, 26.1 Applicable Code: 2016 Received: 25 July 2016 Completed: 08 September 2016 AUTH/2861/7/16 - Anonymous v Bristol-Myers Squibb Promotion of Daklinza No breach: 2, 9.1, 26.1 Applicable Code: 2016 Received: 29 July 2016 Completed: 02 September 2016 AUTH/2851/6/16 - Anonymous, contactable v Novo Nordisk Alleged promotion of Tresiba to the public No breach: 2, 9.1, 26.1 Applicable Code: 2016 Received: 15 June 2016 Completed: 18 August 2016 AUTH/2845/5/16 - CSL Behring v Swedish Orphan Biovitrum Charity Ball No breach: 2, 9.1, 12.1, 18.1, 22.1 Applicable Code: 2016 Received: 12 May 2016 Completed: 18 August 2016 AUTH/2823/2/16 - Anonymous, contactable v Grunenthal Conduct of representatives Breach: 2, 9.1, 15.4, 15.9, 23.1, 29 No breach: 2, 9.1, 18.1 Applicable Code: 2016 Received: 23 February 2016 Completed: 16 August 2016 AUTH/2854/7/16 - Voluntary admission by Boehringer Ingelheim Failure to certify the final form of promotional material Breach: 9.1, 14.1 Applicable Code: 2016 Received: 06 July 2016 Completed: 08 August 2016 AUTH/2848/5/16 - Voluntary admission by Ferring Representative-facilitated letter Breach: 9.1, 12.1, 15.2 No breach: 2 Applicable Code: 2016 Received: 26 May 2016 Completed: 22 July 2016 AUTH/2836/4/16 - AstraZeneca v Janssen – Promotion of Invokana Promotion of Invokana Breach: 3.2, 7.2, 7.4 No breach: 2, 7.2, 7.3, 7.4, 9.1 Applicable Code: 2016 Received: 11 April 2016 Completed: 21 July 2016 AUTH/2850/6/16 - Anonymous, non-contactable v Sunovion Disparagement at a meeting Breach: 8.2, 9.1 Applicable Code: 2016 Received: 13 June 2016 Completed: 13 July 2016 AUTH/2844/5/16 - Voluntary admission by Amdipharm Mercury Email sent by a representative Breach: 7.2, 7.4, 9.1, 14.1 No breach: 15.4 Applicable Code: 2016 Received: 11 May 2016 Completed: 07 July 2016 AUTH/2820/2/16 - Media criticism - Media/PMCPA Director v Hospira Arrangements for an overseas meeting Breach: 2, 9.1, 18.1, 22.1, 23.1 No breach: 22.2 Applicable Code: 2016 Received: 17 February 2016 Completed: 05 July 2016 AUTH/2846/5/16 - Voluntary admission by Janssen Failure to sit the examination for representatives within one year Breach: 9.1, 16.3 Applicable Code: 2016 Received: 20 May 2016 Completed: 04 July 2016 AUTH/2837/4/16 - Anonymous employee v Leo In-house communications material and reporting line of a medical science liaison team No breach: 2, 9.1, 26.1 Applicable Code: 2016 Received: 12 April 2016 Completed: 03 June 2016 AUTH/2833/4/16 - ALK-Abello/PMCPA Director v Bausch & Lomb Breach of undertaking Breach: 9.1, 29 No breach: 2 Applicable Code: 2016 Received: 04 April 2016 Completed: 31 May 2016 AUTH/2822/2/16 - Bayer v Daiichi-Sankyo Promotion of Lixiana Breach: 3.2, 7.2, 7.4, 7.8, 7.10, 9.1 No breach: 3.2, 7.2, 7.3, 7.4, 7.8, 7.9, 7.10, 8.1, 9.1 Applicable Code: 2016 Received: 23 February 2016 Completed: 16 May 2016 AUTH/2839/4/16 - Anonymous v Merck Sharp & Dohme Diabetes meeting sponsorship No breach: 2, 9.1, 9.10, 22.4 Applicable Code: 2016 Received: 19 April 2016 Completed: 10 May 2016 AUTH/2824/2/16 - Anonymous v Chiesi Conduct of employees No breach: 2, 9.1, 15.1 Applicable Code: 2016 Received: 24 February 2016 Completed: 18 April 2016 AUTH/2819/2/16 - General Practitioner v Otsuka Jinarc patient materials No breach: 2, 9.1, 26.1, 26.2 Applicable Code: 2016 Received: 23 March 2016 Completed: 23 March 2016

9.2 All material and activities must recognise the special nature of medicines and the professional standing of the audience to which they are directed and must not be likely to cause offence.

9.3 The name or photograph of a member of a health profession must not be used in any way that is contrary to the conventions of that profession.

9.4 Promotional material must not imitate the devices, copy, slogans or general layout adopted by other companies in a way that is likely to mislead or confuse.

9.5 Promotional material must not include any reference to the Commission on Human Medicines, the Medicines and Healthcare products Regulatory Agency or the licensing authority, unless this is specifically required by the licensing authority.

  • Clause 9.5 MHRA Drug Safety Update

    Where factual safety information given in promotional material is based on advice in the MHRA Drug Safety Update, the information can be referenced to that publication.

9.6 Reproductions of official documents must not be used for promotional purposes unless permission has been given in writing by the appropriate body.

9.7 Extremes of format, size or cost of material must be avoided.

Informational or educational materials must be inexpensive, directly relevant to the practice of medicine or pharmacy and directly beneficial to the care of patients.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

9.8 Postcards, other exposed mailings, envelopes or wrappers must not carry matter which might be regarded as advertising to the public, contrary to Clause 26.1.

  • Clause 9.8 Reply Paid Cards

    Reply paid cards which are intended to be returned to companies through the post and which relate to a prescription only medicine should not bear both the name of the medicine and information as to its usage but may bear one or the other.

9.9 The telephone, text messages, email, telemessages, facsimile, automated calling systems and other electronic data communications must not be used for promotional purposes, except with the prior permission of the recipient.

  • Clause 9.9 Unsubscribing to emails

    Where permission to use emails for promotional purposes has been given by a recipient, each email sent should inform the recipient as to how to unsubscribe to them.

  • Clause 9.9 Responding to emails

    An unsolicited enquiry received by email or an unsolicited enquiry received by post which  includes an email address can be responded to by email without specific permission, consent
    to do so being implied in such circumstances. There is no need to inform recipients as to how to unsubscribe to an email response to an enquiry.

  • Clause 9.9 Remote Detailing

    When promotion is carried out remotely, such as by telephone call, web chat or other online calls, prior permission from the recipient must be obtained in advance or at the start of the contact or call. In setting up the contact or call, full details must be given of the company the caller will represent, their role and the purpose of the call. Arrangements made to discuss a specific product should be adhered to.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

AUTH/3177/3/19 - Anonymous v Grunenthal Breach: 4.1, 4.3, 4.9, 9.1, 9.9, 14.1, 26.1, 26.2, 28.1 No breach: 7.10, 16.1, 26.3 Applicable Code: 2016 Received: 19 March 2019 Completed: 02 October 2019 AUTH/3166/2/19 - Complainant v Sanofi Breach: 9.1, 14.5, 26.1, 26.2 No breach: 2, 4.1, 4.2, 4.3, 4.4, 4.9, 9.9, 11.1, 12.1, 14.1, 16.1, 28.1, 28.6 Applicable Code: 2016 Received: 27 February 2019 Completed: 11 June 2019 AUTH/3051/6/18 - Complainant v Alexion Breach: 9.1 No breach: 2, 9.9, 26.1, 26.2 Applicable Code: 2016 Received: 26 June 2018 Completed: 14 February 2019 AUTH/2985/10/17 - Pharmacist v Sun Pharma Email Promotion of Gemcitabine Breach: 7.2, 7.4 No breach: 9.9 Applicable Code: 2016 Received: 19 October 2017 Completed: 04 June 2018 AUTH/2976/9/17 - Hospital Consultant v AstraZeneca Email promotion of Qtern Breach: 7.2, 9.1, 9.9, 11.1, 12.1 Applicable Code: 2016 Received: 09 September 2017 Completed: 20 November 2017 AUTH/2948/3/17 - General Practitioner v Novo Nordisk Promotion of Tresiba Breach: 7.2, 7.3 No breach: 7.2, 7.3, 9.1, 9.9 Applicable Code: 2016 Received: 21 March 2017 Completed: 21 July 2017 AUTH/2828/3/16 - Clinical Nurse Specialist v Vifor Conduct of representatives Breach: 2, 7.2, 7.4, 7.9, 9.1, 9.9, 15.2, 15.9 No breach: 15.4 Applicable Code: 2016 Received: 21 March 2016 Completed: 07 December 2016 AUTH/2818/1/16 - Clinical Commissioning Group employee v Pfizer Email about a webinar Breach: 12.1, 22.4 No breach: 9.9, 11.2 Applicable Code: 2016 Received: 05 January 2016 Completed: 19 February 2016

9.10 Material relating to medicines and their uses, whether promotional or not, and information relating to human health or diseases which is sponsored by a pharmaceutical company must clearly indicate that it has been sponsored by that company.

The only exception to this is market research material which need not reveal the name of the company involved but must state that it is sponsored by a pharmaceutical company.

  • Clause 9.10 Declaration of Sponsorship

    The declaration of sponsorship must be sufficiently prominent to ensure that readers of sponsored material are aware of it at the outset.

    The wording of the declaration must be unambiguous so that readers will immediately understand the extent of the company’s involvement and influence over the material. This is particularly important when companies are involved in the production of material which is circulated by an otherwise wholly independent party, such as supplements to health professional journals.

  • Clause 9.10 Market Research

    Where market research is carried out by an agency on behalf of a pharmaceutical company, the agency must reveal the name of its client to the Prescription Medicines Code of Practice Authority when the Authority requests it to do so. When commissioning market research, a company must take steps to ensure that its identity would be so made known to the Authority should a request for that information be made.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

AUTH/3173/3/19 - Anonymous v Novo Nordisk Breach: 15.2 No breach: 1.11, 2, 9.1, 9.10, 12.1, 26.1 Applicable Code: 2016 Received: 18 March 2019 Completed: 14 October 2019 AUTH/3176/3/19 - Complainant v Orion Breach: 9.1, 9.10 No breach: 2, 4.1, 4.3, 4.4, 4.6, 4.8, 4.9, 12.1, 14.1 Applicable Code: 2016 Received: 23 March 2019 Completed: 02 October 2019 AUTH/3133/12/18 - Anonymous v Novo Nordisk Breach: 9.1, 9.10, 22.4 No breach: 2, 14, 18, 19, 20, 23, 24, 26, 28 Applicable Code: 2016 Received: 11 December 2018 Completed: 30 July 2019 AUTH/3167/2/19 - Complainant/Director v Novartis No breach: 2, 4.1, 9.1, 9.10, 12.1, 26.1, 29 Applicable Code: 2016 Received: 27 February 2019 Completed: 18 June 2019 AUTH/3028/3/18 - Ex-Employee v AbbVie Production of a poster and use of case studies Breach: 9.1, 9.10, 14.1 No breach: 2, 15.2 Applicable Code: 2016 Received: 23 March 2018 Completed: 17 October 2018 AUTH/3034/4/18 - Health professional v AstraZeneca Patient engagement webpages Breach: 4.1, 4.5 No breach: 9.10 Applicable Code: 2016 Received: 26 April 2018 Completed: 04 October 2018 AUTH/2988/10/17 - Employee v Otsuka Manager’s use of LinkedIn to promote medicines Breach: 3.1, 3.2, 4.1, 7.2, 9.1, 14.1, 26.1 No breach: 1.2, 2, 9.10, 12.1, 22, 26.1 Applicable Code: 2016 Received: 31 October 2017 Completed: 25 January 2018 AUTH/2890/11/16 - Health professional v Novo Nordisk Company website Breach: 9.10, 14.5, 26.2 No breach: 4.1, 4.6, 9.1, 14.5, 26.1 Applicable Code: 2016 Received: 18 November 2016 Completed: 04 April 2017 AUTH/2849/6/16 - Consultant oncologist and pharmacist v Lilly Oncology handbook Breach: 2, 7.2, 7.4, 9.1 No breach: 2, 9.1, 9.10, 12.1 Applicable Code: 2016 Received: 03 June 2016 Completed: 07 November 2016 AUTH/2839/4/16 - Anonymous v Merck Sharp & Dohme Diabetes meeting sponsorship No breach: 2, 9.1, 9.10, 22.4 Applicable Code: 2016 Received: 19 April 2016 Completed: 10 May 2016